Antonio Di Biagio
Antonio Di Biagio
Ospedale Policlinico San Martino Genova
Verified email at
Cited by
Cited by
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
Maraviroc for previously treated patients with R5 HIV-1 infection
RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ...
New England Journal of Medicine 359 (14), 1429-1441, 2008
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
Bloodstream infections in critically ill patients with COVID‐19
DR Giacobbe, D Battaglini, L Ball, I Brunetti, B Bruzzone, G Codda, ...
European journal of clinical investigation 50 (10), e13319, 2020
Whole-genome sequencing reveals host factors underlying critical COVID-19
A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ...
Nature 607 (7917), 97-103, 2022
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2015
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring
G Gatti, A Di Biagio, R Casazza, C De Pascalis, M Bassetti, M Cruciani, ...
Aids 13 (15), 2083-2089, 1999
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
P Maggi, A Di Biagio, S Rusconi, S Cicalini, M D’Abbraccio, G d’Ettorre, ...
BMC infectious diseases 17, 1-17, 2017
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015
Linezolid in the treatment of Gram-positive prosthetic joint infections
M Bassetti, F Vitale, G Melica, E Righi, A Di Biagio, L Molfetta, F Pipino, ...
Journal of Antimicrobial Chemotherapy 55 (3), 387-390, 2005
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
M Mikulska, LA Nicolini, A Signori, A Di Biagio, C Sepulcri, C Russo, ...
Plos one 15 (8), e0237831, 2020
Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study
DR Giacobbe, D Battaglini, EM Enrile, C Dentone, A Vena, C Robba, ...
Journal of clinical medicine 10 (4), 555, 2021
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
A Vena, DR Giacobbe, A Di Biagio, M Mikulska, L Taramasso, A De Maria, ...
Clinical Microbiology and Infection 26 (11), 1537-1544, 2020
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver international 37 (4), 514-528, 2017
Weight gain: a possible side effect of all antiretrovirals
L Taramasso, E Ricci, B Menzaghi, G Orofino, S Passerini, G Madeddu, ...
Open forum infectious diseases 4 (4), ofx239, 2017
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study
GV De Socio, E Ricci, P Maggi, G Parruti, G Pucci, A Di Biagio, L Calza, ...
American journal of hypertension 27 (2), 222-228, 2014
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe
A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ...
The Journal of infectious diseases 207 (8), 1216-1220, 2013
The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient—a case study
C Sepulcri, C Dentone, M Mikulska, B Bruzzone, A Lai, D Fenoglio, ...
Open forum infectious diseases 8 (11), ofab217, 2021
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation
F Marras, E Nicco, F Bozzano, A Di Biagio, C Dentone, E Pontali, S Boni, ...
Proceedings of the National Academy of Sciences 110 (29), 11970-11975, 2013
The system can't perform the operation now. Try again later.
Articles 1–20